Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2013
10/09/2013CN102641254B Preparation method of aspirin enteric-coated sustained-release preparation
10/09/2013CN102641253B Valsartan sustained release tablet and preparation method thereof
10/09/2013CN102579364B Sustained or controlled release microsphere of valnemulin/valnemulin salts and preparation method thereof
10/09/2013CN102552814B Traditional Chinese drug for treating diabetes
10/09/2013CN102526521B Traditional Chinese medicine composition powder for treating nephropathogenic infectious bronchitis in chicken
10/09/2013CN102512395B Huperzine osmotic-pump controlled release tablet
10/09/2013CN102488722B Preparation method and quality detection method of bupleurum oral solution
10/09/2013CN102485257B Chinese medicinal composition with lung ventilating, stagnated qi dispersing, heat clearing and phlegm eliminating effects and its preparation method
10/09/2013CN102440961B Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof
10/09/2013CN102430082B Traditional Chinese medicine sachet and preparation method thereof
10/09/2013CN102423352B Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases
10/09/2013CN102397404B Tea paste for treating limb anesthesia dolorosa and preparation method thereof
10/09/2013CN102379857B Levetiracetam slow release medicinal composition and preparation method thereof
10/09/2013CN102366406B Salmeterol/fluticasone aerosol preparation with hydrofluoroalkane as propellent
10/09/2013CN102325524B Process to make fusidic acid cream
10/09/2013CN102292068B Transdermal delivery of diclofenac, carbamazepine and benzydamine
10/09/2013CN102210693B Method for preparing aspirin and dipyridamole multilayer tablets
10/09/2013CN101917973B Process for recovering flunixin from pharmaceutical compositions
10/09/2013CN101485765B Chinese medicine powder for treating dysentery of livestock and preparation method thereof
10/09/2013CN101005827B Articles for the delivery of therapeutic agents
10/08/2013US8552145 Vaccine for modulating between T1 and T2 immune responses
10/08/2013US8552102 Coating composition
10/08/2013US8552089 Ink composition for forming light shielding film of organic semiconductor device, method for forming light shielding film, and organic transistor device having light shielding film
10/08/2013US8552064 Suramin and derivatives thereof as topical microbicide and contraceptive
10/08/2013US8552025 Stable methylnaltrexone preparation
10/08/2013US8551975 Hyaluronic acid in soft gel form
10/08/2013US8551951 Pharmaceutical preparations and methods for inhibiting tumors
10/08/2013US8551917 Use of prolines for improving growth and/or yield
10/08/2013US8551542 Methods and compositions for increasing growth hormones
10/08/2013US8551531 Pentablock polymers
10/08/2013US8551530 Nanoparticle isoflavone compositions and methods of making and using the same
10/08/2013US8551529 Composition for the production of tablets, and method for the production of said composition
10/08/2013US8551528 Diketopiperazine microparticles with defined specific surface areas
10/08/2013US8551527 Process for stabilizing an adjuvant containing vaccine composition
10/08/2013US8551526 Preparation of drug particles using evaporation precipitation into aqueous solutions
10/08/2013US8551524 Anti-diabetic combinations
10/08/2013US8551523 Sustained release aminopyridine composition
10/08/2013US8551522 Sustained-release formulation
10/08/2013US8551521 Stable pharmaceutical composition and methods of using same
10/08/2013US8551520 Controlled release hydrocodone
10/08/2013US8551518 Lotioned wipe product to reduce adhesion of soils or exudates to the skin
10/08/2013US8551517 Substrates providing multiple releases of active agents
10/08/2013US8551516 Administration of non-oral androgenic steroids to women
10/08/2013US8551515 Pharmacokinetics of S-adenosylmethionine formulations
10/08/2013US8551506 Compositions and methods for administering compartmentalized frozen particles
10/08/2013US8551505 Compositions and methods for therapeutic delivery with frozen particles
10/08/2013US8551504 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols
10/08/2013US8551503 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols
10/08/2013US8551501 Chitin microparticles and their medical uses
10/08/2013US8551498 Solid composition containing Bacillus-type non-pathogenic bacterial spores
10/08/2013US8551491 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
10/08/2013US8551455 Tooth cleaning kit comprising at least one set of chewing gum pieces
10/08/2013US8551454 Device for intranasal administration
10/08/2013US8551069 Methods and apparatus for treating contrast nephropathy
10/08/2013CA2687505C Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
10/08/2013CA2625568C Ophthalmic emulsions containing prostaglandins
10/08/2013CA2610708C Method and composition for transdermal drug delivery
10/08/2013CA2596178C Method for producing a drug extract that contains hydroxystilbene
10/08/2013CA2495048C Hemostatic compositions and devices
10/08/2013CA2493629C Pramipexole once-daily dosage form
10/03/2013WO2013149190A1 Pharmaceutical compositions and methods for treatment of fungal infections
10/03/2013WO2013149141A1 Lipid-derived neutral nanoparticles
10/03/2013WO2013149140A1 Ionizable cationic lipids
10/03/2013WO2013149109A1 Colchicine formulations; methods of making; and methods of use thereof
10/03/2013WO2013149075A1 Compositions and methods for treating or preventing diseases associated with oxidative stress
10/03/2013WO2013149074A1 Lyophilization of synthetic liposomal pulmonary surfactant
10/03/2013WO2013149056A1 Device, system, and method for delivery of sugar glass stabilized compositions
10/03/2013WO2013149013A1 Lyophilization of synthetic liposomal pulmonary surfactant
10/03/2013WO2013148931A1 Multifunctional nanoparticles
10/03/2013WO2013148824A1 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC-3 shRNA
10/03/2013WO2013148682A1 Methods and compositions for controlled delivery of phytochemical agents
10/03/2013WO2013148541A1 DIETHER BASED BIODEGRADABLE CATIONIC LIPIDS FOR siRNA DELIVERY
10/03/2013WO2013148376A1 Acoustically responsive particles
10/03/2013WO2013148264A1 Controlling extracellular matrix protein microstructure with ultrasound
10/03/2013WO2013148258A1 Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
10/03/2013WO2013148186A1 Lipid-coated nucleic acid nanostructures of defined shape
10/03/2013WO2013148158A1 Laser-actuated therapeutic nanoparticles
10/03/2013WO2013147921A1 Polyvinylpyrrolidone-containing acetaminophen liquid formulations
10/03/2013WO2013147687A1 A nicotine oral delivery product containing a powder enclosed in a water insoluble pouch, wherein said powder comprises nicotine and a chewing gum composition
10/03/2013WO2013147645A1 Method for producing drugs and biologically active agents
10/03/2013WO2013147559A1 A liquid formulation of highly concentrated long-acting human growth hormone conjugate
10/03/2013WO2013147462A1 Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
10/03/2013WO2013147452A1 Pharmaceutical composition in form of non-aqueous liquid comprising revaprazan or its salt
10/03/2013WO2013147451A1 Pharmaceutical composition containing branched chain amino acid, and production method therefor
10/03/2013WO2013147414A1 Pharmaceutical composition and preparation method thereof
10/03/2013WO2013147329A1 Composition for enteric hard capsule and enteric hard capsule prepared using the composition
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
10/03/2013WO2013147135A1 Controlled-release pharmaceutical composition
10/03/2013WO2013147082A1 Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient
10/03/2013WO2013147000A1 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
10/03/2013WO2013146917A1 Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose
10/03/2013WO2013146649A1 Diquafosol-containing eye drop
10/03/2013WO2013146471A1 Drug composition, and soft capsule containing same
10/03/2013WO2013146386A1 Sustained-release local anesthetic preparation
10/03/2013WO2013146376A1 Coating composition and medical device
10/03/2013WO2013145750A1 Capsule pharmaceutical preparation
10/03/2013WO2013145749A1 Capsule preparation
10/03/2013WO2013145379A1 Capsule disintegrable in large-intestine-specific manner
10/03/2013WO2013144916A1 Tranilast compositions and cocrystals
10/03/2013WO2013144814A1 Stable ready-to-use pharmaceutical composition of pemetrexed